MedPath

The effect of vit D supplement on ejection fraction, ferritin and hypertention in beta-thalassaemia major patients

Not Applicable
Conditions
cooley anemia.
Beta thalassaemia
Registration Number
IRCT2016022110222N5
Lead Sponsor
Vice chancellor for research of Shahrekord University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
33
Inclusion Criteria

patients with thalassemia major with vitamin D levels less than 74 nmol . L or 29 ng . ml Exclusion criteria:other concurrent diseases, including heart disease; Diabetes; Hepatitis; Hypo-parathyroid; Cardiac output less than 35%

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cardiac out put. Timepoint: Baseline andThree months later. Method of measurement: echocardiography.;Blood pressure. Timepoint: Baseline andThree months later. Method of measurement: Barometer.;Pulmonary hypertention. Timepoint: Baseline and quarterly. Method of measurement: echocardiography.;Ferittin level. Timepoint: Baseline andThree months later. Method of measurement: blood sample.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath